Remove 2030 Remove Communication Remove Packaging
article thumbnail

Lilly and EVA Pharma to aid affordable insulin access in Africa

European Pharmaceutical Review

Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Communication with WHO encourage implementation of and accountability for the commitments and contributions toward improving access to insulin.

article thumbnail

Disrupted medical conferences: 2022 and beyond

pharmaphorum

Moreover, no attendee data was available for physical symposia, whereas all virtual symposia packages provided full attendee metrics analyses. Since then, many societies have indeed made discernible progress towards digital transformation of their events and communications practices. Postscript. www.conferencecompass.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Philips on designing innovation and cultivating partnerships – part two

pharmaphorum

It’s a package, and sometimes we deploy one or two modules, sometimes multiple modules in a project. “That is something very unique because there are lots of patient apps out there, but they do not communicate with the doctor. The only aspects Philips does not provide are health workers and the supply chain for drugs.

article thumbnail

Veterinary Medicine Outlook: 5 Changes and Trends Impacting Veterinary Practices

epicur

Continued Burnout and Veterinary Staff Shortages Unemployment rates continue to affect the veterinary industry, with estimates that by 2030 there will be a shortage of 15,000 veterinarians , making the demand for more workers increasingly urgent. It often starts with communication.

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

The challenge for pharma in reducing its carbon footprint A recent study presented at COP27 , found that just 4% of biotechnology and pharmaceutical companies were currently on track to meet Paris 2030 climate goals, with the pharmaceutical industry being among the world’s largest carbon emitters.

article thumbnail

GSK, Sanofi and Takeda join AI and robotics push for Singapore biomanufacturing

Pharmaceutical Technology

Kenilworth, NJ, US) is investing $500 million in its Singapore facilities, including setting up a secondary packaging facility and building an inhaler production plant. The BioPIPS project is in line with Singapore’s wider “Manufacturing 2030” program, which aims to boost the country’s manufacturing by 50%.

Vaccines 105